Adenocarcinoma or adeno-squamous carcinoma stage IB3-IIIC2

Clinical trials for Adenocarcinoma or adeno-squamous carcinoma stage IB3-IIIC2 explained in plain language.

Never miss a new study

Get alerted when new Adenocarcinoma or adeno-squamous carcinoma stage IB3-IIIC2 trials appear

Sign up with your email to follow new studies for Adenocarcinoma or adeno-squamous carcinoma stage IB3-IIIC2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New drug cocktail aims to stop cervical cancer return

Disease control Not yet recruiting

This phase II trial tests whether adding pembrolizumab and lenvatinib to standard chemoradiation and brachytherapy can improve outcomes for adults with high-risk locally advanced cervical cancer. About 87 participants will receive the drug combination and be followed for two year…

Matched conditions: ADENOCARCINOMA OR ADENO-SQUAMOUS CARCINOMA STAGE IB3-IIIC2

Phase 2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

Adenocarcinoma or adeno-squamous carcinoma stage IB3-IIIC2

Get alerted when new Adenocarcinoma or adeno-squamous carcinoma stage IB3-IIIC2 trials appear

New drug cocktail aims to stop cervical cancer return